Cargando…
A pharmacogenomic method for individualized prediction of drug sensitivity
Identifying the best drug for each cancer patient requires an efficient individualized strategy. We present MATCH (Merging genomic and pharmacologic Analyses for Therapy CHoice), an approach using public genomic resources and drug testing of fresh tumor samples to link drugs to patients. Valproic ac...
Autores principales: | Cohen, Adam L, Soldi, Raffaella, Zhang, Haiyu, Gustafson, Adam M, Wilcox, Ryan, Welm, Bryan E, Chang, Jeffrey T, Johnson, Evan, Spira, Avrum, Jeffrey, Stefanie S, Bild, Andrea H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Molecular Biology Organization
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3159972/ https://www.ncbi.nlm.nih.gov/pubmed/21772261 http://dx.doi.org/10.1038/msb.2011.47 |
Ejemplares similares
-
Gene-expression patterns in peripheral blood classify familial breast cancer susceptibility
por: Piccolo, Stephen R., et al.
Publicado: (2015) -
Integrating heterogeneous drug sensitivity data from cancer pharmacogenomic studies
por: Pozdeyev, Nikita, et al.
Publicado: (2016) -
2356: openSESAME: a “search engine” for discovering drug-disease connections by leveraging publicly available high-throughput experimental data
por: Gower, Adam C., et al.
Publicado: (2018) -
A genomic approach to predict synergistic combinations for breast cancer treatment
por: Soldi, Raffaella, et al.
Publicado: (2011) -
Genomic pathway analysis reveals that EZH2 and HDAC4 represent mutually exclusive epigenetic pathways across human cancers
por: Cohen, Adam L, et al.
Publicado: (2013)